Filing Details

Accession Number:
0001225208-11-015740
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-02 16:13:00
Reporting Period:
2011-06-01
Filing Date:
2011-06-02
Accepted Time:
2011-06-02 16:13:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
901219 Human Genome Sciences Inc HGSI Biological Products, (No Disgnostic Substances) (2836) 223178468
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346164 Curran Simpson 14200 Shady Grove Road
Rockville MD 20850
Sr. Vp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-01 22,904 $12.56 68,694 No 4 M Direct
Common Stock Disposition 2011-06-01 22,904 $27.11 45,790 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option - Right to Buy Disposition 2011-06-01 22,904 $0.00 22,904 $12.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,193 2015-01-17 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person and Charles Schwab effective March 18, 2011.
  2. This transaction was executed in multiple trades at prices ranging from $26.71 to $27.44. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer, or the security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
  3. These options have vested and are exercisable.